|
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
|
05 December 2018 |
|
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
|
13 April 2018 |
|
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
|
27 March 2018 |
|
GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy Ellipta
|
23 November 2017 |
|
GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles
|
28 November 2016 |
|
GSK announce positive results from the COPD Salford Lung Study
|
06 September 2016 |
|
GSK and Verily to establish Galvani Bioelectronics - a new company dedicated to the development of bioelectronic medicines
|
09 August 2016 |
|
GSK names winners of 2015 Discovery Fast Track Challenge
|
07 March 2016 |
|
Four inspiring innovations which help reduce child deaths in developing countries share $1 million prize from GSK and Save the Children
|
23 February 2016 |
|
GSK receives European marketing authorisation for Nucala® (mepolizumab) in 31 countries
|
03 December 2015 |